Evidence map›Paper›PMID 29772652›Full record

ArticleViruses2018

Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIV

Manxue Jia, Hong Lu, Xiang-Peng Kong, Cecilia Cheng-Mayer, Xueling Wu

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Manxue JiaAaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY 10016, USA. mjia@adarc.org.
Hong LuAaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY 10016, USA. lhong@adarc.org.
Xiang-Peng KongSchool of Medicine, New York University, New York, NY 10016, USA. xiangpeng.kong@med.nyu.edu.ORCID 0000-0001-5773-2681
Cecilia Cheng-MayerAaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY 10016, USA. cmayer@adarc.org.
Xueling WuAaron Diamond AIDS Research Center, Affiliate of The Rockefeller University, New York, NY 10016, USA. xwu@adarc.org.
Aaron Diamond AIDS Research Center · USNew York University · US

Funding

Deep Sequencing to Identify B-Cell Precursors of HIV-1 Neutralizing AntibodiesR01AI114380 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI WU, XUELING · 2014 to 2018
$2.6M
NIAID NIH HHS R01 AI114380
6 · The paper itself

Abstract

Simian-human immunodeficiency virus (SHIV) infection provides a relevant animal model to study HIV-1 neutralization breadth. With previously identified SHIV

Indexed as

Amino Acid SequenceAnimalsAntibodies, NeutralizingEpitope MappingEpitopesHIV-1HIV AntibodiesHIV Envelope Protein gp120Macaca mulattaModels, MolecularNeutralization TestsSensitivity and SpecificitySequence AlignmentSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusTime FactorsAntibodies, NeutralizingEpitopesHIV AntibodiesHIV Envelope Protein gp120HIV vaccineneutralizing antibodyrhesus macaqueSHIV

Identifiers

PMID29772652
PMCPMC5977255
OpenAlexW2803953011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.